These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

269 related items for PubMed ID: 8103066

  • 1. Effects of IL-12 on the generation of cytotoxic activity in human CD8+ T lymphocytes.
    Mehrotra PT, Wu D, Crim JA, Mostowski HS, Siegel JP.
    J Immunol; 1993 Sep 01; 151(5):2444-52. PubMed ID: 8103066
    [Abstract] [Full Text] [Related]

  • 2. Synergistic effects of IL-7 and IL-12 on human T cell activation.
    Mehrotra PT, Grant AJ, Siegel JP.
    J Immunol; 1995 May 15; 154(10):5093-102. PubMed ID: 7730615
    [Abstract] [Full Text] [Related]

  • 3. Synergy between interleukin 4 and interleukin 2 conveys resistance to cyclosporin A during primary in vitro activation of murine CD8 cytotoxic T cell precursors.
    Bubeck R, Miethke T, Heeg K, Wagner H.
    Eur J Immunol; 1989 Apr 15; 19(4):625-30. PubMed ID: 2499483
    [Abstract] [Full Text] [Related]

  • 4. Lymphocytes infiltrating ovarian malignant ascites: modulation of IL-2-induced proliferation by IL-4 and of selective increase in CD8+ T cells by TNF-alpha.
    Ioannides CG, Rashed S, Fisk B, Fan D, Itoh K, Freedman RS.
    Lymphokine Cytokine Res; 1991 Aug 15; 10(4):307-15. PubMed ID: 1932375
    [Abstract] [Full Text] [Related]

  • 5. Synergy of tumor necrosis factor and interleukin 2 in the activation of human cytotoxic lymphocytes: effect of tumor necrosis factor alpha and interleukin 2 in the generation of human lymphokine-activated killer cell cytotoxicity.
    Owen-Schaub LB, Gutterman JU, Grimm EA.
    Cancer Res; 1988 Feb 15; 48(4):788-92. PubMed ID: 3257408
    [Abstract] [Full Text] [Related]

  • 6. Cellular and molecular mechanisms of the IL-12-induced increase in allospecific murine cytolytic T cell activity. Implications for the age-related decline in CTL.
    Bloom ET, Horvath JA.
    J Immunol; 1994 May 01; 152(9):4242-54. PubMed ID: 7908914
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. IL-4 inhibits IL-2-mediated induction of human lymphokine-activated killer cells, but not the generation of antigen-specific cytotoxic T lymphocytes in mixed leukocyte cultures.
    Spits H, Yssel H, Paliard X, Kastelein R, Figdor C, de Vries JE.
    J Immunol; 1988 Jul 01; 141(1):29-36. PubMed ID: 2454260
    [Abstract] [Full Text] [Related]

  • 9. Development of CD8+ effector T cells is differentially regulated by IL-18 and IL-12.
    Okamoto I, Kohno K, Tanimoto T, Ikegami H, Kurimoto M.
    J Immunol; 1999 Mar 15; 162(6):3202-11. PubMed ID: 10092771
    [Abstract] [Full Text] [Related]

  • 10. Heterogeneous mechanisms of human cytotoxic T lymphocyte generation. II. Differential effects of IL-6 on the helper cell-independent generation of CTL from CD8+ precursor subpopulations.
    Bass HZ, Yamashita N, Clement LT.
    J Immunol; 1993 Sep 15; 151(6):2895-903. PubMed ID: 8376760
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Synergistic and antagonistic effects of IL-1 alpha and IL-4, respectively, on the IL-2-dependent growth of a T cell receptor-gamma delta+ human T leukemia cell line.
    Santoli D, O'Connor R, Cesano A, Phillips P, Colt TL, Lange B, Clark SC, Rovera G.
    J Immunol; 1990 Jun 15; 144(12):4703-11. PubMed ID: 2351825
    [Abstract] [Full Text] [Related]

  • 13. Regulation of human cytotoxic T lymphocyte development by IL-7.
    Hickman CJ, Crim JA, Mostowski HS, Siegel JP.
    J Immunol; 1990 Oct 15; 145(8):2415-20. PubMed ID: 2145359
    [Abstract] [Full Text] [Related]

  • 14. Differential development of CD4 and CD8 cytotoxic T cells (CTL) in PBMC across the leprosy spectrum; IL-6 with IFN-gamma or IL-2 generate CTL in multibacillary patients.
    de la Barrera S, Finiasz DM, Fink S, Valdez R, Bottasso O, Balina LM, Sasiain MC.
    Int J Lepr Other Mycobact Dis; 1997 Mar 15; 65(1):45-55. PubMed ID: 9207753
    [Abstract] [Full Text] [Related]

  • 15. In vitro interleukin 12 activation of peripheral blood CD3(+)CD56(+) and CD3(+)CD56(-) gammadelta T cells from glioblastoma patients.
    Fujimiya Y, Suzuki Y, Katakura R, Miyagi T, Yamaguchi T, Yoshimoto T, Ebina T.
    Clin Cancer Res; 1997 Apr 15; 3(4):633-43. PubMed ID: 9815731
    [Abstract] [Full Text] [Related]

  • 16. IL-4 regulates IL-2 induction of lymphokine-activated killer activity from human lymphocytes.
    Kawakami Y, Custer MC, Rosenberg SA, Lotze MT.
    J Immunol; 1989 May 15; 142(10):3452-61. PubMed ID: 2654291
    [Abstract] [Full Text] [Related]

  • 17. Generation of memory CD4+, CD8+, CD45RO+ and CD16- lymphocytes activated with IL-2, INF-gamma, and TNF-alpha with specific cytotoxicity against autologous cervical cancer cells in a mixed leukocyte-tumour cell culture.
    Rangel R, Rocha L, Ramirez JL, Ibarra MJ, Solorza G, Monroy A, Ramirez MA, Herrera A, Weiss-Steider B.
    Eur Cytokine Netw; 1995 May 15; 6(3):195-202. PubMed ID: 8589277
    [Abstract] [Full Text] [Related]

  • 18. IL-2 and IL-6 synergize to augment the pore-forming protein gene expression and cytotoxic potential of human peripheral blood T cells.
    Smyth MJ, Ortaldo JR, Bere W, Yagita H, Okumura K, Young HA.
    J Immunol; 1990 Aug 15; 145(4):1159-66. PubMed ID: 2143209
    [Abstract] [Full Text] [Related]

  • 19. Promotion of human T lymphocyte proliferation by IL-4.
    Mitchell LC, Davis LS, Lipsky PE.
    J Immunol; 1989 Mar 01; 142(5):1548-57. PubMed ID: 2783946
    [Abstract] [Full Text] [Related]

  • 20. Cellular and molecular mechanisms of activation of MHC nonrestricted cytotoxic cells by IL-12.
    Cesano A, Visonneau S, Clark SC, Santoli D.
    J Immunol; 1993 Sep 15; 151(6):2943-57. PubMed ID: 8104216
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.